See more : Huabao International Holdings Limited (HUABF) Income Statement Analysis – Financial Results
Complete financial analysis of Thermic Sciences International (ENDO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Thermic Sciences International, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- KEC International Limited (KEC.BO) Income Statement Analysis – Financial Results
- China United Travel Co.,Ltd (600358.SS) Income Statement Analysis – Financial Results
- Kinross Gold Corporation (KG.SW) Income Statement Analysis – Financial Results
- McLaren Resources Inc. (MCL.CN) Income Statement Analysis – Financial Results
- Major Cineplex Lifestyle Leasehold Property Fund. (MJLF.BK) Income Statement Analysis – Financial Results
Thermic Sciences International (ENDO)
About Thermic Sciences International
Thermic Sciences International develops and sells hemp based products. The company offers hemp formulation-based health and wellness solutions, as well as cosmeceuticals, nutraceuticals, and food brands. It also provides over the counter products for hair and skin include Hempery miracle oil, a skin care solution; Hemp milk body wash, a creamy soap; Hemp lotion bars for moisturizing hands and body; Hemp rose soap; and Hemtastique lip and body balms. The company also develops products for ailments, such as acquired immune deficiency syndrome/human immunodeficiency virus, asthma, cancer, glaucoma, influenza, pain management, and post-traumatic stress disorder. It distributes its products in the United States, Canada, Colombia, Ireland, India, China, Japan, South Korea, and Afghanistan through online and in retail stores. The company was formerly known as OmniCanna Health Solutions, Inc. Thermic Sciences International was incorporated in 1969 and is based in Colorado Springs, Colorado.
| Metric | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.63M | 1.15M | 567.24K | 37.44K | 0.00 | 0.00 | 0.00 | 1.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 333.95K | 248.37K | 29.19K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.63M | 820.62K | 318.87K | 8.25K | 0.00 | 0.00 | 0.00 | 1.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 71.08% | 56.21% | 22.03% | 0.00% | 0.00% | 0.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.89M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 743.43K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.75M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 53.05K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 743.43K | 111.24K | 127.42K | 40.85K | 25.83K | 2.36M | 1.80M | 824.70K | 23.76K | 7.90K | 46.68K | 5.78K | 180.26K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 743.43K | 111.24K | 127.42K | 40.85K | 25.83K | 4.25M | 1.80M | 824.70K | 23.76K | 7.90K | 46.68K | 5.78K | 180.26K |
| Cost & Expenses | 743.43K | 111.24K | 127.42K | 40.85K | 25.83K | 4.25M | 2.14M | 1.07M | 52.95K | 7.90K | 46.68K | 5.78K | 180.26K |
| Interest Income | 0.00 | 0.00 | 546.00 | 0.00 | 3.56K | 3.80K | 32.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.97M | 222.52K | 5.10M | 211.50K | 725.72K | 582.95K | 44.24K | 27.50K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 0.00 | 0.00 | 76.69K | 532.44K | 1.11M | 488.99K | 20.55K | 11.43K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -1.34M | -1.76M | -126.87K | 424.12K | -1.15M | -2.13M | -1.92M | -494.40K | -73.82K | -7.90K | -46.68K | -5.78K | -180.26K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -131.04% | -83.23% | -116.99% | -41.42% | 0.00% | 0.00% | 0.00% | -18,026,100.00% |
| Operating Income | -743.43K | -111.24K | -127.42K | -40.85K | -25.83K | -2.62M | -981.47K | -505.84K | -15.51K | -7.90K | -46.68K | -5.78K | -180.26K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -161.10% | -85.01% | -89.18% | -41.42% | 0.00% | 0.00% | 0.00% | -18,026,100.00% |
| Total Other Income/Expenses | -2.57M | -1.87M | -5.18M | -278.97K | -1.85M | -579.15K | 913.94K | -65.46K | 0.00 | 0.00 | 0.00 | 0.00 | 180.26K |
| Income Before Tax | -3.31M | -1.98M | -5.30M | -319.83K | -1.87M | 0.00 | 0.00 | -336.60K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -59.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 5.10M | 245.00K | 1.97M | 579.15K | 54.43K | -141.74K | 73.82K | 7.90K | 1.60M | 5.78K | 180.26K |
| Net Income | -3.31M | -1.98M | -5.30M | -353.33K | -3.11M | -3.20M | -1.04M | -364.10K | -73.82K | -7.90K | -1.60M | -5.78K | -180.26K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -196.71% | -89.72% | -64.19% | -197.18% | 0.00% | 0.00% | 0.00% | -18,026,200.00% |
| EPS | -0.10 | -0.11 | -0.83 | -0.07 | -1.43 | -2.11 | -0.76 | -0.35 | -0.09 | -0.01 | -1.42 | -0.01 | -0.10 |
| EPS Diluted | -0.10 | -0.11 | -0.83 | -0.07 | -1.43 | -2.11 | -0.76 | -0.35 | -0.09 | -0.01 | -1.42 | -0.01 | -0.10 |
| Weighted Avg Shares Out | 32.71M | 17.54M | 6.40M | 5.31M | 2.18M | 1.52M | 1.37M | 1.04M | 814.79K | 1.12M | 1.13M | 1.06M | 1.88M |
| Weighted Avg Shares Out (Dil) | 32.71M | 17.54M | 6.40M | 5.31M | 2.18M | 1.52M | 1.37M | 1.04M | 814.79K | 1.12M | 1.13M | 1.06M | 1.88M |
Thermic Science Files 2021 Second Quarter Financials Ending June 30, 2021, Continuing to Bring the Company in Compliance with the OTC Market to Pink Current Status and No Shell Designation by Filing its Financials & Business Activities Reporting Requirements
NASHVILLE, TN / ACCESSWIRE / August 17, 2021 / Thermic Science International Corporation, formerly known as Omnicanna Health Solutions, Inc. aka Endocan Corporation. (WKN:A1W61J) (ISIN:US29271J1097) (OTC:ENDO), is pleased to announce the unaudited interim consolidated financial results of the Company for...
Thermic Science Prepares to File the New Rule 15c2-11 Amendments Ahead of Schedule, the September 2021 Deadline for Required Financials & Filings Will Bring the Company Current and in Compliance With the OTC Market Reporting Changes
NASHVILLE, TN / ACCESSWIRE / July 16, 2021 / Thermic Science International Corporation, formerly known as Omnicanna Health Solutions, Inc. aka ENDOCAN CORP. (WKN: A1W61J) (ISIN:US29271J1097) (OTC PINK:ENDO), is pleased to announce that the company has completed its required compliance...
Thermic Science Proudly Receives OTC Markets Registration Confirmation, Makes Payment of Initial Exchange Fees to Begin Uploading its Financials and Reporting Requirements to Bring the Company Current and in Compliance with the Amended Rule 15c2-11
NASHVILLE, TN / ACCESSWIRE / June 1, 2021 / Thermic Science International Corporation, formerly known as Omnicanna Health Solutions, Inc. aka Endocan Corporation. (WKN:A1W61J) (ISIN:US29271J1097) (OTC PINK:ENDO), is proud to announce it has officially received OTC Markets registration confirmations, completing...
Thermic Science Sends First North American Shipment of Thermic Infrared Heating Paint for N.A. Certification, Retail Consumer Sales, and Further R&D for Its Advanced Thermic Technology to Successfully Disrupt the Immense and Disadvantaged North American Power and Heating Industry
NASHVILLE, TN / ACCESSWIRE / May 17, 2021 / Thermic Science International Corporation, formerly known as Omnicanna Health Solutions, Inc. aka ENDOCAN CORP. (WKN:A1W61J)(ISIN:US29271J1097)(OTC PINK:ENDO), is pleased to announce that the first batch of the North American Shipments of the Thermic...
OMNICANNA/Thermic Appoints Mr. Hendrik Schutte as Research Director of Electrical Components, Sales & Development (DECS), Renewable Thermic Solid State Battery Power Units and Thermic Self-Generating Electrical Power Units, International Sales & Distribution
NASHVILLE, TN / ACCESSWIRE / March 19, 2021 / Thermic Sciences International, former known as Omnicanna Health Solutions, Inc. aka ENDOCAN CORP. (WKN: A1W61J, ISIN: US29271J1097, OTC PINK:ENDO), is pleased to announce the appointment of Mr.
OMNICANNA/Thermic Sciences Acquires 100% of Another European Groundbreaking Technology; Litcoat Electroluminescent Paint, Known as Multi-Colored Electrical Lighting Paint for Cars, Boats, Motorcycles, Billboards, Buildings, Houses, Bicycles, and So Much More
NASHVILLE, TN / ACCESSWIRE / March 8, 2021 / Thermic Sciences International, former known as Omnicanna Health Solutions, Inc. aka ENDOCAN CORP. (WKN: A1W61J, ISIN: US29271J1097, OTC PINK:ENDO), acquires another groundbreaking technology to adds to its growing list of acquisitions...
Source: https://incomestatements.info
Category: Stock Reports